Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Cefdiwel O
Cefdiwel O is a powerful antibacterial formulation combining Cefpodoxime Proxetil and Ofloxacin, designed to provide broad-spectrum protection against bacterial infections. It effectively combats a range of infections affecting the respiratory, urinary, gastrointestinal, and skin systems.
Uses of Cefdiwel O
Treatment of respiratory tract infections (bronchitis, pneumonia, sinusitis).
Management of urinary tract infections (UTIs) and kidney infections.
Effective against skin and soft tissue infections.
Helps control gastrointestinal infections caused by bacteria.
Benefits of Cefdiwel O
Dual-action formula enhances bacterial elimination.
Broad-spectrum efficacy against gram-positive and gram-negative bacteria.
Reduced resistance development due to combination therapy.
Well-tolerated and safe, with excellent bioavailability for optimal absorption.
Mechanism of Action of Cefdiwel O
Cefpodoxime, a cephalosporin, inhibits bacterial cell wall synthesis, leading to bacterial lysis and death. Ofloxacin, a fluoroquinolone, interferes with bacterial DNA replication, preventing bacterial growth. Together, they provide synergistic bactericidal activity, making Cefdiwel O highly effective for treating infections.